In men, p53 mutation has also been observed in advanced and metastatic PC, but it is believed to be associated with the signaling pathway along CD24 [132], a cell surface coding protein involved in promoting immune escape, thus favoring tumor progression and metastatic capacity [133]. This evidence concerns the gene TP53 and neoplasm.